MedTrace Logo

Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients

NCT02858856 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2017-09-15

No results posted yet for this study

Summary

This is a pilot study that investigate efficacy and safety of Sipjeondaebo-tang on fatigue of patients with breast carcinoma receiving chemotherapy.

Conditions

  • Breast Carcinoma

Interventions

DRUG

Sipjeondaebo-tang

Herbal medicine which is a compound of 10 herbs.

Sponsors & Collaborators

  • Catholic Kwandong University

    collaborator OTHER

  • Kyunghee University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-20
Primary Completion
2018-03-31
Completion
2018-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02858856 on ClinicalTrials.gov